A detailed history of Gofen & Glossberg LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Gofen & Glossberg LLC holds 4,253 shares of EW stock, worth $287,205. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,253
Previous 4,200 1.26%
Holding current value
$287,205
Previous $347,000 8.65%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 13, 2023

BUY
$68.3 - $87.44 $3,619 - $4,634
53 Added 1.26%
4,253 $317,000
Q1 2022

Apr 14, 2022

SELL
$101.96 - $128.34 $90,234 - $113,580
-885 Reduced 17.4%
4,200 $494,000
Q4 2021

Jan 25, 2022

SELL
$106.37 - $130.68 $36,804 - $45,215
-346 Reduced 6.37%
5,085 $659,000
Q3 2021

Oct 13, 2021

SELL
$102.91 - $122.75 $174,947 - $208,675
-1,700 Reduced 23.84%
5,431 $615,000
Q2 2021

Jul 13, 2021

SELL
$83.84 - $104.76 $86,271 - $107,798
-1,029 Reduced 12.61%
7,131 $739,000
Q1 2021

Apr 13, 2021

SELL
$78.68 - $90.67 $15,736 - $18,134
-200 Reduced 2.39%
8,160 $683,000
Q4 2020

Jan 15, 2021

SELL
$71.69 - $91.23 $42,010 - $53,460
-586 Reduced 6.55%
8,360 $763,000
Q2 2020

Jul 13, 2020

BUY
$57.54 - $76.95 $374,815 - $501,252
6,514 Added 267.85%
8,946 $618,000
Q4 2019

Jan 28, 2020

SELL
$71.7 - $82.09 $5,520 - $6,320
-77 Reduced 3.07%
2,432 $567,000
Q3 2019

Oct 10, 2019

BUY
$61.55 - $75.43 $5,047 - $6,185
82 Added 3.38%
2,509 $552,000
Q2 2019

Jul 12, 2019

BUY
$55.74 - $64.41 $4,905 - $5,668
88 Added 3.76%
2,427 $448,000
Q1 2019

Apr 11, 2019

SELL
$47.89 - $64.05 $4,310 - $5,764
-90 Reduced 3.71%
2,339 $448,000
Q4 2018

Jan 15, 2019

BUY
$46.41 - $56.94 $19,677 - $24,142
424 Added 21.15%
2,429 $372,000
Q1 2018

Apr 11, 2018

SELL
$37.19 - $47.45 $16,921 - $21,589
-455 Reduced 18.5%
2,005 $280,000
Q2 2017

Aug 16, 2017

BUY
N/A
2,460
2,460 $291,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Gofen & Glossberg LLC Portfolio

Follow Gofen & Glossberg LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gofen & Glossberg LLC , based on Form 13F filings with the SEC.

News

Stay updated on Gofen & Glossberg LLC with notifications on news.